SEC Form 4 · accession 0001127602-19-008811

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Feb 26, 2019

Accepted (ET)

Feb 28, 2019 · 9:53 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 26, 2019	S	100	$140.72	D	286,657	D
Common Stock	Feb 26, 2019	S	100	$140.725	D	286,557	D
Common Stock	Feb 26, 2019	S	200	$140.78	D	286,357	D
Common Stock	Feb 26, 2019	S	100	$141.04	D	286,257	D
Common Stock	Feb 26, 2019	S	200	$141.34	D	286,057	D
Common Stock	Feb 26, 2019	S	300	$141.35	D	285,757	D
Common Stock	Feb 26, 2019	S	30	$141.53	D	285,727	D
Common Stock	Feb 26, 2019	S	30	$141.585	D	285,697	D
Common Stock	Feb 26, 2019	S	300	$141.59	D	285,397	D
Common Stock	Feb 26, 2019	S	60	$141.595	D	285,337	D
Common Stock	Feb 26, 2019	S	430	$141.63	D	284,907	D
Common Stock	Feb 26, 2019	S	200	$141.635	D	284,707	D
Common Stock	Feb 26, 2019	S	100	$141.64	D	284,607	D
Common Stock	Feb 26, 2019	S	100	$141.73	D	284,507	D
Common Stock	Feb 26, 2019	S	100	$141.74	D	284,407	D
Common Stock	Feb 26, 2019	S	500	$141.90	D	283,907	D
Common Stock	Feb 26, 2019	S	200	$142.08	D	283,707	D
Common Stock	Feb 26, 2019	S	200	$142.09	D	283,507	D
Common Stock	Feb 26, 2019	S	100	$142.10	D	283,407	D
Common Stock	Feb 26, 2019	S	3	$142.27	D	283,404	D
Common Stock	Feb 26, 2019	S	3	$143.00	D	283,401	D
Common Stock	Feb 26, 2019	S	200	$143.09	D	283,201	D
Common Stock	Feb 26, 2019	S	200	$143.23	D	283,001	D

No Table II lines on this filing.